SUBSCRIBE
SUBSCRIBE

MAIA Biotechnology

IN THE PRESS
Press Releases
MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
May 15, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Announces Director Participation in Recent Private Placement
May 14, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders
April 1, 2025
 · 
4 min read
Press Releases
MAIA Biotechnology Announces Poster Presentation at ESMO’s European Lung Cancer Congress 2025
March 25, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug
March 20, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO
March 20, 2025
 · 
4 min read
Press Releases
MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients
February 27, 2025
 · 
4 min read
Press Releases
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
February 26, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million
February 25, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces Private Placement of $2,715,000
February 18, 2025
 · 
4 min read
Load More
JOBS